drugset / Trial / NCT00574704
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to test the efficacy of the combination treatment AllQbG10 in patients with perennial allergic rhinoconjunctivitis due to house dust mite allergy in a double-blind, placebo-controlled setting
Timeline
- Start
- 2006-09
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CYT003-AllQbG10 | Unknown | — | Subcutaneous |
| Subject | CYT003-QbG10 | Vaccine | — | Subcutaneous |
| Subject | CYT005-AllQbG10 | Vaccine | — | Subcutaneous |
| Comparator | House dust mite allergen extract | Unknown | — | Subcutaneous |